Report cover image

Clinical Trial Kits Market Share, Size, Trends, Industry Analysis Report, By Service (Kitting Solutions {Drug Kits, Sample Collection kits}, Logistics {transportation, warehousing & storage, others}), By Phase (Phase I, Phase II, Phase III and Phase IV),

Publisher Polaris Market Research & Consulting LLP
Published Sep 01, 2025
Length 110 Pages
SKU # PLRS20470415

Description

The global clinical trial kits market is anticipated to grow up to USD 3.99 billion by 2034 according to a new study by Polaris Market Research. The report “Clinical Trial Kits Market Share, Size, Trends, Industry Analysis Report, By Service (Kitting Solutions {Drug Kits, Sample Collection kits}, and Logistics {transportation, warehousing & storage, others}), By Phase (Phase I, Phase II, Phase III and Phase IV), By Region; Segment Forecast, 2025–2034” gives a detailed insight into current market dynamics and provides analysis on future market growth.

The major factors driving the global market include the globalization of clinical trials and rising clinical trial complexity. Remote medical trial services are becoming an essential part of patient satisfaction, safety, and retention. At present, pharmaceutical companies are partnering with global logistics partners in order to provide direct-to-patient services.

The logistics segment is leading the global industry in 2024. This huge market share can be attributed to the growing demand for services in order to simplify the overall logistics process in medical tests. Additionally, pharmaceutical companies are partnering up with global logistics companies in order to provide remote services. This is anticipated to drive the growth of the segment over the coming years.

Based on Phase, the phase III segment is anticipated to dominate the industry in 2024. The basic objective of Phase III is to validate the safety and efficacy of a new medicine or vaccine, confirm the dosage levels, and discover the side effects. The number of clinical tests on humans increases in Phase III. Most of the medicines that passed phase II clinical trials generally fail in Phase III due to the side effects of therapeutic effectiveness.

The growing R&D investments along with the rapid technological advancements are further anticipated to drive the market growth. Alpha Laboratories designs, manufactures and assembles kits such as SpeciSafe packs, 95kPa pouchs, absorbents, Pastette, and others. These new products enable the market players to offer highly competitive pricing along with faster bespoke solutions where required. Additionally, Q2 Solutions offerings can help in Covid-19 clinical trial, as they offer innovative & technologically advanced solutions such as SARS-CoV-2 virus & antibody detection, SARS-CoV-2 viral genome analysis, immunologic profiling of humans, and vaccine neutralization testing. Thus, these innovative introductions may further support the industry demand across the globe.

Market participants such as Alpha Laboratories, Brooks Life Science, Almac Group, Cerba research, Charles River Laboratories, Clinigen, LabConnect, Labcorp Drug Development, Marken a UPS company, Patheon, Precision Medicine Group, Q2 Solutions.

Various industry players are launching new products into the global clinical trial kit industry in order to expand. For instance, In April 2021, Parexel partnered with Veeva Systems in order to improve their medical test delivery and to enhance Veeva’s cloud technology.

Polaris Market research has segmented the clinical trial kits market report on the basis of service, phase, and region:

Clinical Trial Kits, Service Outlook (Revenue - USD Billion, 2020 - 2034)

Kitting Solutions

Drug kits

Sample collection kits

Logistics

Warehousing & Storage

Transportation

Others

Clinical Trial Kits, Phase Outlook (Revenue - USD Billion, 2020 - 2034)

Phase I

Phase II

Phase III

Phase IV

Clinical Trial Kits, Regional Outlook (Revenue - USD Billion, 2020 - 2034)

North America

U.S

Canada

Europe

France

Germany

UK

Italy

Spain

Netherlands

Austria

Asia Pacific

China

India

Japan

Malaysia

South Korea

Indonesia

Latin America

Mexico

Brazil

Argentina

Middle East & Africa

UAE

Saudi Arabia

Israel

South Africa

Table of Contents

110 Pages
1. Introduction
1.1. Report Description
1.1.1. Objectives of the Study
1.1.2. Market Scope
1.1.3. Assumptions
1.2. Stakeholders
2. Executive Summary
2.1. Market Highlights
3. Research Methodology
3.1. Overview
3.1.1. Data Mining
3.2. Data Sources
3.2.1. Primary Sources
3.2.2. Secondary Sources
4. U.S. Phosphoramidite Market Insights
4.1. U.S. Phosphoramidite Market – Market Snapshot
4.2. U.S. Phosphoramidite Market Dynamics
4.2.1. Drivers and Opportunities
4.2.1.1. Expansion of the Biotechnology and Pharmaceutical Sectors in the U.S.
4.2.1.2. Increasing Focus on Personalized Medicine and Precision Healthcare
4.2.2. Restraints and Challenges
4.2.2.1. High Production Costs and Complex Manufacturing Processes
4.3. Porter’s Five Forces Analysis
4.3.1. Bargaining Power of Suppliers (Moderate)
4.3.2. Threats of New Entrants: (Low)
4.3.3. Bargaining Power of Buyers (Moderate)
4.3.4. Threat of Substitute (Moderate)
4.3.5. Rivalry among existing firms (High)
4.4. PESTEL Analysis
4.5. U.S. Phosphoramidite Market Trends
4.6. Value Chain Analysis
5. U.S. Phosphoramidite Market, by Type
5.1. Key Findings
5.2. Introduction
5.2.1. U.S. Phosphoramidite Market, by Type, 2020-2034 (USD Million)
5.3. DNA Phosphoramidites
5.3.1. Global Phosphoramidite Market, by DNA Phosphoramidites, by Region, 2020-2034 (USD Million)
5.4. RNA Phosphoramidites
5.4.1. Global Phosphoramidite Market, by RNA Phosphoramidites, by Region, 2020-2034 (USD Million)
5.5. Labeled Phosphoramidites
5.5.1. Global Phosphoramidite Market, by Labeled Phosphoramidites, by Region, 2020-2034 (USD Million)
5.6. Modifier Phosphoramidites
5.6.1. Global Phosphoramidite Market, by Modifier Phosphoramidites, by Region, 2020-2034 (USD Million)
5.7. Other Types
5.7.1. Global Phosphoramidite Market, by Other Types, by Region, 2020-2034 (USD Million)
6. U.S. Phosphoramidite Market, by Application
6.1. Key Findings
6.2. Introduction
6.2.1. U.S. Phosphoramidite Market, by Application, 2020-2034 (USD Million)
6.3. Drug Discovery & Development
6.3.1. Global Phosphoramidite Market, by Drug Discovery & Development, by Region, 2020-2034 (USD Million)
6.4. Diagnostics Development
6.4.1. Global Phosphoramidite Market, by Diagnostics Development, by Region, 2020-2034 (USD Million)
6.5. Gene Editing & Synthetic Biology
6.5.1. Global Phosphoramidite Market, by Gene Editing & Synthetic Biology, by Region, 2020-2034 (USD Million)
6.6. Other Applications
6.6.1. Global Phosphoramidite Market, by Other Applications, by Region, 2020-2034 (USD Million)
7. U.S. Phosphoramidite Market, by End User
7.1. Key Findings
7.2. Introduction
7.2.1. U.S. Phosphoramidite Market, by Application, 2020-2034 (USD Million)
7.3. Pharmaceutical and Biotechnology Companies
7.3.1. Global Phosphoramidite Market, by Pharmaceutical and Biotechnology Companies, by Region, 2020-2034 (USD Million)
7.4. Academic and Research Institutes
7.4.1. Global Phosphoramidite Market, by Academic and Research Institutes, by Region, 2020-2034 (USD Million)
7.5. Other End Users
7.5.1. Global Phosphoramidite Market, by Other End Users, by Region, 2020-2034 (USD Million)
8. U.S. Phosphoramidite Market, by Country
8.1. Key Findings
8.2. Introduction
8.2.1. U.S. Phosphoramidite Market Assessment, By Country, 2020-2034 (USD Million)
8.2.2. U.S. Phosphoramidite Market
8.2.2.1. U.S.: Phosphoramidite Market, by Type, 2020-2034 (USD Million)
8.2.2.2. U.S.: Phosphoramidite Market, by Application, 2020-2034 (USD Million)
8.2.2.3. U.S.: Phosphoramidite Market, by End User, 2020-2034 (USD Million)
9. Competitive Landscape
9.1. Expansion and Acquisition Analysis
9.1.1. Expansion
9.1.2. Acquisitions
9.2. Partnerships/Collaborations/Agreements/Exhibitions
10. Company Profiles
10.1. Biosynth Carbosynth
10.1.1. Company Overview
10.1.2. Financial Performance
10.1.3. Product Benchmarking
10.1.4. Recent Development
10.2. BOC Sciences
10.2.1. Company Overview
10.2.2. Financial Performance
10.2.3. Product Benchmarking
10.2.4. Recent Development
10.3. ChemGenes Corp.
10.3.1. Company Overview
10.3.2. Financial Performance
10.3.3. Product Benchmarking
10.3.4. Recent Development
10.4. emp BIOTECH
10.4.1. Company Overview
10.4.2. Financial Performance
10.4.3. Product Benchmarking
10.4.4. Recent Development
10.5. GenScript
10.5.1. Company Overview
10.5.2. Financial Performance
10.5.3. Product Benchmarking
10.5.4. Recent Development
10.6. Glen Research
10.6.1. Company Overview
10.6.2. Financial Performance
10.6.3. Product Benchmarking
10.6.4. Recent Development
10.7. Hunan Honya Biotech Co., Ltd.
10.7.1. Company Overview
10.7.2. Financial Performance
10.7.3. Product Benchmarking
10.7.4. Recent Development
10.8. Integrated DNA Technologies, Inc.
10.8.1. Company Overview
10.8.2. Financial Performance
10.8.3. Product Benchmarking
10.8.4. Recent Development
10.9. Lumiprobe
10.9.1. Company Overview
10.9.2. Financial Performance
10.9.3. Product Benchmarking
10.9.4. Recent Development
10.10. Merck KGaA
10.10.1. Company Overview
10.10.2. Financial Performance
10.10.3. Product Benchmarking
10.10.4. Recent Development
10.11. Thermo Fisher Scientific
10.11.1. Company Overview
10.11.2. Financial Performance
10.11.3. Product Benchmarking
10.11.4. Recent Development
10.12. TriLink BioTechnologies
10.12.1. Company Overview
10.12.2. Financial Performance
10.12.3. Product Benchmarking
10.12.4. Recent Development

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us